[
  {
    "ts": "2025-10-17T22:42:00+00:00",
    "headline": "Top Analyst Reports for Home Depot, Boeing & Progressive",
    "summary": "Analysts spotlight Home Depot, Boeing, and Progressive in today's top Zacks reports, revealing growth drivers, risks, and key performance trends.",
    "url": "https://finance.yahoo.com/news/top-analyst-reports-home-depot-224200151.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a56bb67a-4726-3a85-962b-8b9b3702ff89",
      "content": {
        "id": "a56bb67a-4726-3a85-962b-8b9b3702ff89",
        "contentType": "STORY",
        "title": "Top Analyst Reports for Home Depot, Boeing & Progressive",
        "description": "",
        "summary": "Analysts spotlight Home Depot, Boeing, and Progressive in today's top Zacks reports, revealing growth drivers, risks, and key performance trends.",
        "pubDate": "2025-10-17T22:42:00Z",
        "displayTime": "2025-10-17T22:42:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3ae84033e92ef7b498075b308712c747",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kz4t1awoxunHEaTbJb5lUA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ae84033e92ef7b498075b308712c747.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YZSS0_.XXqbcwEuKLPxygA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ae84033e92ef7b498075b308712c747.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-analyst-reports-home-depot-224200151.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-analyst-reports-home-depot-224200151.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            },
            {
              "symbol": "SNEJF"
            },
            {
              "symbol": "SONY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BA"
            },
            {
              "symbol": "HD"
            },
            {
              "symbol": "PGR"
            },
            {
              "symbol": "FEIM"
            },
            {
              "symbol": "UBCP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T21:45:02+00:00",
    "headline": "Pfizer (PFE) Beats Stock Market Upswing: What Investors Need to Know",
    "summary": "Pfizer (PFE) concluded the recent trading session at $24.51, signifying a +1.16% move from its prior day's close.",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-beats-stock-market-214502070.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f14e6210-9e96-37f7-9edf-c75e482b8840",
      "content": {
        "id": "f14e6210-9e96-37f7-9edf-c75e482b8840",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Beats Stock Market Upswing: What Investors Need to Know",
        "description": "",
        "summary": "Pfizer (PFE) concluded the recent trading session at $24.51, signifying a +1.16% move from its prior day's close.",
        "pubDate": "2025-10-17T21:45:02Z",
        "displayTime": "2025-10-17T21:45:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T5hbaObWi1jST2y00rKbhQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oc5UMRa8ji_BfGLG4u5KZw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-beats-stock-market-214502070.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-beats-stock-market-214502070.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T18:02:00+00:00",
    "headline": "Biotech Is Finally Rallying. Why Mizuho’s Jared Holz Is Optimistic This Time.",
    "summary": "Barron’s called Holz to ask about what’s happened to the biotech sector since our healthcare roundtable.",
    "url": "https://www.barrons.com/articles/biotech-stock-analyst-rally-startups-a707d4d0?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e24778ae-b1aa-31a2-8672-e36b0130196b",
      "content": {
        "id": "e24778ae-b1aa-31a2-8672-e36b0130196b",
        "contentType": "STORY",
        "title": "Biotech Is Finally Rallying. Why Mizuho’s Jared Holz Is Optimistic This Time.",
        "description": "",
        "summary": "Barron’s called Holz to ask about what’s happened to the biotech sector since our healthcare roundtable.",
        "pubDate": "2025-10-17T18:02:00Z",
        "displayTime": "2025-10-17T18:02:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e24778ae-b1aa-31a2-8672-e36b0130196b/biotech-is-finally-rallying-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/f4148820b5a883da1e77599101b84644",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.TT29mo_RAtH8a4O5x51XQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/f4148820b5a883da1e77599101b84644.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FDWpp7cidD8dXg6taeQRwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/f4148820b5a883da1e77599101b84644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/biotech-stock-analyst-rally-startups-a707d4d0?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "IBB"
            },
            {
              "symbol": "XBI"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T16:11:00+00:00",
    "headline": "Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?",
    "summary": "JNJ's strong Q3 results, upbeat sales outlook and expanding drug pipeline highlight resilience despite Stelara LOE.",
    "url": "https://finance.yahoo.com/news/buy-sell-hold-j-j-161100770.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c4d54ccd-bec6-3a7a-b19d-a5427b5df0f9",
      "content": {
        "id": "c4d54ccd-bec6-3a7a-b19d-a5427b5df0f9",
        "contentType": "STORY",
        "title": "Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?",
        "description": "",
        "summary": "JNJ's strong Q3 results, upbeat sales outlook and expanding drug pipeline highlight resilience despite Stelara LOE.",
        "pubDate": "2025-10-17T16:11:00Z",
        "displayTime": "2025-10-17T16:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tugIemz.T.iquqxVIoxpHw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SHyaOdZAc4DXCya2O4.DtQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-j-j-161100770.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-j-j-161100770.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T11:00:00+00:00",
    "headline": "ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain",
    "summary": "DURHAM, N.C., October 17, 2025--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 96-week findings from PASO DOBLE (GeSIDA 11720 study) showing that Dovato (dolutegravir/lamivudine [DTG/3TC]) is as effective as Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide fumarate [BIC/FTC/TAF]) in maintaining virological suppression in adults with HIV-1. Individuals taking Dovato also experienced statistically signifi",
    "url": "https://finance.yahoo.com/news/viiv-healthcare-announces-96-week-110000504.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a8953851-4422-3bdf-95cf-b427a07a447a",
      "content": {
        "id": "a8953851-4422-3bdf-95cf-b427a07a447a",
        "contentType": "STORY",
        "title": "ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain",
        "description": "",
        "summary": "DURHAM, N.C., October 17, 2025--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 96-week findings from PASO DOBLE (GeSIDA 11720 study) showing that Dovato (dolutegravir/lamivudine [DTG/3TC]) is as effective as Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide fumarate [BIC/FTC/TAF]) in maintaining virological suppression in adults with HIV-1. Individuals taking Dovato also experienced statistically signifi",
        "pubDate": "2025-10-17T11:00:00Z",
        "displayTime": "2025-10-17T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/55da12c94ac81f0a6b0dae2fc7fb8c9b",
          "originalWidth": 480,
          "originalHeight": 409,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dwSJ233W4Dl._K5wgkO4BA--~B/aD00MDk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/55da12c94ac81f0a6b0dae2fc7fb8c9b.cf.webp",
              "width": 480,
              "height": 409,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cdX9oRcBWhBFO9JIg5VjhA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/55da12c94ac81f0a6b0dae2fc7fb8c9b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/viiv-healthcare-announces-96-week-110000504.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/viiv-healthcare-announces-96-week-110000504.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "4507.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]